Skip to main content
PACB logo
PACB
(NASDAQ)
Pacific Biosciences of California, Inc.
$1.40-- (--)
Loading... - Market loading

Pacific Biosciences of California (PACB) Stock Price & Financial Analysis

Pacific Biosciences of California Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.36 - $1.43
52-Week High$2.73
52-Week Low$1.09
Open$1.36
Volume4.32M
Average Volume (3M)6.07M
Market Cap428.15M
Shares Outstanding305.82M
Price to Sales (P/S)2.68
Price to Book (P/B)180.96
EV/EBITDA-10.09
Revenue (TTM)160.03M
Net Income (TTM)-128.58M
Free Cash Flow (TTM)-116.21M
EPS (TTM)$-0.43
Profit Margin-80.34%
Operating Margin-101.76%
Return on Equity (ROE)-5434.32%
Debt to Equity297.29
50-Day MA$1.45
200-Day MA$1.68
52-Week Change6.87%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Pacific Biosciences of California

What is the current stock price for PACB?

As of the latest trading session, PACB stock trades at $1.40. The 52-week range is $1.09–$2.73, with a day range of $1.36–$1.43.

What is the P/E ratio for PACB?

The P/E ratio (Price-to-Earnings) for PACB is shown in the Key Statistics section. This valuation metric helps compare Pacific Biosciences of California, Inc. to industry peers.

Does PACB pay dividends?

Pacific Biosciences of California does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PACB?

Based on 4 analysts, the consensus for PACB is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PACB?

Pacific Biosciences of California's market capitalization is $428.1M, classifying it as a small-cap company. Pacific Biosciences of California operates in the Healthcare sector within the Medical Devices industry.